Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial

Open access
Jiang, Qinyu, Qi, Yu, Zhou, Meiyan, Dong, Yaqi, Zheng, Wenting, Zhu, Lijiao, Li, Yanyu, Zhou, Hai, Wang, Liwei · 2024 · BMC Anesthesiology

Abstract

BACKGROUND: The development of postpartum depression has been linked to fluctuations in the levels of neurotransmitters in the human body, such as 5-hydroxytryptamine (5-HT), dopamine (DA), noradrenaline (Norepinephrine, NE), and brain derived neurotrophic factor (BDNF). Research has indicated that the antidepressant effect of esketamine are mediated by monoamine transmitters and neurotrophic factors. Therefore, we postulate that intravenous administration of esketamine in patients with postpartum depression may alter the serum concentrations of these neurotransmitters. METHODS: Three hundred fifteen patients with postpartum depression were selected and divided into two groups based on randomized numerical expression: esketamine (E) group (0. 25 mg/kg esketamine) and control (C) group (a same volume of 0.9% saline), all the drugs were pumped for 40 min. After the end of drug pumping, all patients were continuously observed for 2 h. Changes in serum levels of 5-HT, DA, NE, BDNF were recorded before drug administration and on the 3rd day after drug administration. The scores of Edinburgh Postnatal Depression Scale (EPDS) were calculated before drug administration, and on the 3rd day and on the 30th day after drug administration. Dizziness, headache, nausea, vomiting, drowsiness, and feeling of detachment occurred were recorded within 2 h after drug administration. RESULTS: Before drug administration, the serum concentrations of 5-HT,DA,BDNF,NE in Group E and Group C were namely (0. 91 ± 0. 19 vs. 0. 98 ± 0. 21, P = 0. 181), (2. 38 ± 0. 35 vs. 2. 32 ± 0. 32, P = 0. 491), (3. 07 ± 0. 89 vs 3. 02 ± 0. 88, P = 0. 828), (39. 79 ± 7. 78 vs 41. 34 ± 10. 03, P = 0. 506). On the third day post-medication, the serum concentrations of 5-HT,DA,BDNF,NE in Group E and Group C were namely (1. 42 ± 0. 35 vs. 0. 96 ± 0. 24, P < 0. 001), (3. 99 ± 0. 17 vs. 2. 41 ± 0. 28, P < 0. 001),(5. 45 ± 0. 81 vs 3. 22 ± 0. 76, P < 0. 001),(44. 36 ± 9. 98 vs 40. 69 ± 11. 75, P = 0. 198). Before medication, the EPDS scores were (16. 15 ± 3. 02 vs 17. 85 ± 3. 89, P = 0. 064). on the third day after medication, the Group E had significantly reduced scores (12. 98 ± 2. 39 vs 16. 73 ± 3. 52, P < 0. 001). On the 30rd day after medication, EPDS scores between the two groups were (16. 34 ± 3. 43 vs 16. 91 ± 4. 02, p = 0. 203). Within 2 h of medication, the rate of adverse events was similar between the two groups. CONCLUSIONS: Small doses of esketamine can increase the serum concentration of 5-HT,DA,BDNF, and in the short term, decrease EPDS scores, and improve postpartum depressive symptoms. TRIAL REGISTRATION: Retrospectively registered in the Chinese Clinical Trial Registry (ChiCTR2300078343, 2023/12/05).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12871-024-02681-9

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow diagram
Fig. 1 Flow diagramCC BY-NC-ND · PubMed Central
Fig. 2 Changes in serum 5-HT/DA/NE/BDNF concentration before and after medication in the two groups. ***P < 0. 01
Fig. 2 Changes in serum 5-HT/DA/NE/BDNF concentration before and after medication in the two groups. ***P < 0. 01CC BY-NC-ND · PubMed Central
Fig. 3 Comparison of Edinburgh Depression Scale (EPDS) scores between the two groups. **P < 0. 05
Fig. 3 Comparison of Edinburgh Depression Scale (EPDS) scores between the two groups. **P < 0. 05CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 8

  1. Liu D, Ma Y, Yu G, Kuang J. Meta analysis of the detection rate of postpartum depression in China. Chinese Journal of Evidence Based Medicine. 2019;19(12):1409–15.
  2. Li L, An X, Zhang J, Huang L, Zhang X. Meta analysis of the detection rate of postpartum depression in elderly mothers in China. Chinese Journal of General Medicine. 2024;27(11):1363–9.
  3. Gu P, Jiang X, Du B, Yao L, Song J. The effect of s-ketamine PCIA on postpartum depression in pregnant women undergoing cesarean section. Chinese Journal of Anesthesiology. 2021;41(3):274–7.
  4. Liu Y, Li X. The effect of s-ketamine combined with hydromorphone on postoperative analgesia and postpartum depression after cesarean section. Shandong Medical Journal. 2021;61(19):84–7.
  5. Zhou Y, Wang S, Yang M, Huang Z, Ma J, Duan K. Analysis of the correlation between BDNF gene polymorphism and postpartum depression in cesarean section women. Chinese Journal of Medicine. 2017;42(6):538–44.
  6. Schwartz J, Murrough JW, Iosifescu DV. Short term ketamine administration for refractory depression: focusing on cardiovascular safety. Psychiatry Danub. 2019;31(Supplementary 3):585–90.
  7. Shang Y, Li S, Zheng Q, et al. Study on the effect of different doses of intravenous ketamine on postoperative depression in cesarean section women. Chinese Maternal and Child Health Research. 2023;34(9):28–34.
  8. Dandan L, Xiao H, Changwei W, et al. Meta-analysis of the effects of perioperative ketamine application on postpartum depression in cesarean section mothers. Journal of Clinical Anesthesiology. 2021;37(05):506–10.

Cited by

See all 18

Metadata

Authors
Jiang, Q., Qi, Y., Zhou, M., Dong, Y., Zheng, W., Zhu, L., Li, Y., Zhou, H., & Wang, L.
Affiliations
Xuzhou Medical College (CN)
Corresponding author
Wang, Liwei
Venue
BMC Anesthesiology
Published
2024-08-19
Volume
24
Issue
1
Pages
293-293
ISSN
1471-2253 (ISSN-L)
OpenAlex
W4401709616
Cited by
14
References
24
Citations by year
2026: 7 · 2025: 5 · 2024: 2
FWCI
5.80
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Anesthesiology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Government of Jiangsu Province
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
esketamine, postpartum depression, serotonin, dopamine, norepinephrine, brain-derived neurotrophic factor, monoamines, antidepressant effects, adverse effects, Edinburgh Postnatal Depression Scale, maternal mental health, NMDA receptor antagonists, ketamine derivatives, neurotrophic factors, depression biomarkers, treatment-resistant depression
MeSH terms
Adult, Antidepressive Agents, Dopamine, Female, Humans, Ketamine, Norepinephrine, Serotonin, Neurotransmitter Agents, Depression, Postpartum, Brain-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12871-024-02681-9
The paper
Jiang, Q., Qi, Y., Zhou, M., Dong, Y., Zheng, W., Zhu, L., Li, Y., Zhou, H., & Wang, L. (2024). Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial. BMC Anesthesiology. https://doi.org/10.1186/s12871-024-02681-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.